EVERSANA Merges with Waltz Health to Create a New Force in Pharma Commercialization and Prescription Drug Access
EVERSANA and Waltz Health announce a merger to form a unified healthcare platform that redefines pharmaceutical commercialization and patient access. The move integrates Waltz Health’s software-powered drug-price marketplaces and direct-to-payer model into EVERSANA’s global commercialization services, creating a next-generation approach for drug access and value in the U.S. healthcare system. EVERSANA is a pioneering leader […]
